http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112812171-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate | 2021-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112812171-B |
| titleOfInvention | Bioactive peptide with amino acid structure VVRKPLNKEGKKP, and preparation method and application thereof |
| abstract | The invention relates to the field of protein, in particular to a bioactive peptide with an amino acid structure of VVRKPLNKEGKKP, a preparation method and application thereof, wherein the amino acid sequence of the bioactive peptide VVRKPLNKEGKKP is shown as SEQ ID NO: 1, the amino acid sequence of the bioactive peptide VVRKPLNKEGKKPR is shown as SEQ ID NO: 2, respectively. In vitro immunoregulation function experiments prove that the bioactive peptides VVRKPLNKEGKKP and VVRKPLNKEGKKPR have good immunoregulation function. The VVRKPLNKEGKKP and VVRKPLNKEGKKPR of the invention have the capability of promoting the increase of the induced amount of the nitric oxide of the macrophage under the condition of certain concentration, thereby improving the capability of the body for resisting the infection of external pathogens, reducing the morbidity of the body, simultaneously promoting the proliferation of the macrophage in vitro, exerting the immunologic function of the body and having very important significance for developing foods, health care products and medicines with immunoregulation function. |
| priorityDate | 2021-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 194.